Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
Recruiting now · Not applicable
Conditions studied: ADHD, Behavioral Addiction
In brief
The main objective of this pilot study is to assess preliminary data on the feasibility of CBT and its evaluation in a randomised trial in patients with co-occurring ADHD and behavioural addiction: Evaluation and comparison of the 12-week retention rate of patients randomised to CBT compared with patients in the 'treatment as usual' control arm. In order to meet the objective, the patient will take part in a standardized assessment, followed by a therapeutic intervention and a new standardized assessment after the intervention. The standardized assessment consists as follows : * firstly, 7 self-questionnaires to be completed by the patient, lasting around 45 min, aimed at assessing his or her socio-demographic data; current symptoms, quality of life and functional impact related to ADHD; impulsivity, emotion regulation and assessment of possible anxiety-depressive disorders. * Then the patient will follow the 10 session of cognitivo behavioural psychotherapy. * At 12-weeks post-inclusion, an assessment visit is carried out during which a battery of tests will be administered. This is followed by a research interview with a professional, aimed at gathering his or her experiences.
Key facts
- Study ID
- NCT06797726
- Run by
- University Hospital, Tours
- People needed
- 54
- Starts
- 2025-05-13
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2025-06-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient over 18 (age ≥ 18 years)
- Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity
- Patient affiliated to a social security scheme
- For patients treated with methylphenidate: no change in treatment dosage during the previous three months.
- For patients not treated with methylphenidate: no introduction of methylphenidate within the next three months.
You may not qualify if…
- Patients with psychotic disorders (assessed by clinician)
- Pregnant or breast-feeding women
- Patients under protective supervision (guardianship or curatorship)
- Persons under court protection
- Persons deprived of their liberty
- Patients who do not meet the eligibility criteria for CBT (e.g., cognitive impairment, hearing impairment).
- Physical inability to participate in CBT sessions (e.g., lack of telephone, foreseeable unavailability).
- Difficulty understanding self-questionnaires, including illiteracy.
- Participation in another interventional research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome.
Where it is running
- CHRU De Tours — Tours, France (enrolling)
- CHU La Cavale Blanche — Brest, France
- Centre Hospitalier Saint Jacques — Nantes, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.